Heart Monitor Co. To Pay $6.4M To Avoid FCA Overbilling Suit
Medical device manufacturer BioTelemetry Inc. entered into a $6.4 million agreement Thursday to prevent a False Claims Act lawsuit being brought by the federal government, which accuses the company of overbilling...To view the full article, register now.
Already a subscriber? Click here to view full article